Lv2
106 积分 2025-05-16 加入
Clofazimine Inhalation Suspension: A Novel Formulation for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease
1天前
已完结
Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance
5个月前
已完结
NIR-II aggregation-induced emission nanoparticles camouflaged with preactivated macrophage membranes for phototheranostics of pulmonary tuberculosis
6个月前
已完结
Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In Vivo
6个月前
已完结
Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles
7个月前
已完结
Encapsulation and stability of clofazimine liposomes
7个月前
已完结
Immune evasion and provocation by Mycobacterium tuberculosis
7个月前
已完结
Multidrug-resistant tuberculosis
7个月前
已完结
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease
8个月前
已完结
Design, development, and characterisation of clofazimine-loaded mannosylated nanostructured lipid carriers: 33-Box-Behnken design approach
8个月前
已完结
皖公网安备34019202002308
